Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection
Masashi Takenaka, Vijay Subramanian, Venkataswarup Tiriveedhi, Donna Phelan, Ramsey Hachem, Elbert Trulock, Andrew E. Gelman, G. Alexander Patterson, Kiyotaka Hoshinaga, Thalachallour Mohanakumar
「Complement activation is not required for obliterative airway disease induced by antibodies to major histocompatibility complex class I: Implications for chronic lung rejection」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。